Company Analysis

BioXcel Therapeutics, Inc. (BTAI)

OTC: BTAI · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2017
Grade3.3
◀ Past 2.9● Present 3.1▶ Future 3.7
1 est.

Filings

351 filings since 2017 beside 321 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Nov 12, 2025.

Filings a yearinsider forms included
494961531111179659
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Oct 30, 2026.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Sep 1, 2026.Bankruptcy or receivership notice (8-K item 1.03): 1 time in the last 36 months, the newest Aug 28, 2026.SEC letters: 5 in the last 36 months, the newest Jan 15, 2025.
Insider forms 321

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 30, 2026 8-K items 2.01, 5.02, 5.03, 9.01 Purchase or sale of a business completed; Officer or director change; Charter, bylaw or fiscal-year change · Current report Oct 26, 2026
Sep 1, 2026 8-K items 2.03, 3.01 New debt or obligation taken on; Listing warning from its exchange · Current report Aug 31, 2026
Aug 28, 2026 8-K items 1.01, 1.03 Major agreement signed; Bankruptcy or receivership notice · Current report Aug 27, 2026
Aug 25, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Aug 24, 2026
Aug 24, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Aug 21, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Aug 10, 2026
Aug 3, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Jul 31, 2026
Jul 6, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
May 15, 2026 SCHEDULE 13G Large holder notice
May 15, 2026 8-K items 2.02, 9.01 Results released · Current report
May 15, 2026 10-Q Quarterly report Mar 31, 2026
Apr 17, 2026 8-K items 3.02, 9.01 Shares sold without registration · Current report Apr 15, 2026
Apr 1, 2026 8-K item 8.01 Other event · Current report
Mar 30, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 27, 2026 S-8 Employee stock plan registration
Mar 27, 2026 10-K Annual report Dec 31, 2025
Mar 27, 2026 8-K items 2.02, 9.01 Results released · Current report
Mar 11, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Mar 10, 2026
Mar 11, 2026 424B5 Shelf offering
Feb 12, 2026 8-K item 8.01 Other event · Current report
Feb 9, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 6, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Feb 4, 2026
Jan 20, 2026 8-K item 8.01 Other event · Current report
Jan 12, 2026 8-K item 8.01 Other event · Current report
Dec 15, 2025 8-K item 5.07 Shareholder vote · Current report Dec 12, 2025
Nov 12, 2025 ARS Annual report to shareholders Dec 31, 2024
Nov 12, 2025 DEF 14A Proxy statement Dec 12, 2025
Nov 12, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 10, 2025 8-K items 8.01, 9.01 Other event · Current report
Oct 31, 2025 PRE 14A Preliminary proxy statement Dec 12, 2025
Oct 30, 2025 8-K item 8.01 Other event · Current report
Oct 14, 2025 8-K item 8.01 Other event · Current report
Oct 1, 2025 SCHEDULE 13G Large holder notice
Sep 15, 2025 8-K items 7.01, 8.01 Investor disclosure (Regulation FD); Other event · Current report
Sep 10, 2025 8-K item 8.01 Other event · Current report
Aug 27, 2025 8-K item 8.01 Other event · Current report
Aug 18, 2025 424B5 Shelf offering
40 of 351 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BTAI · research, not advice